BOS EVENTS
BIOTECH OUTSOURCING EVENTS
BOS Basel 2020
BASEL, SWITZERLAND
BOS Manchester 2020
MANCHESTER, UK
POSTERS
at BOS EVENTS
DATA CENTRE
DOWNLOAD PRESENTATIONS

Record Numbers Attend BOS 2019 in Basel

BOS 2019 took place on the 19th and 20th of June at the Congress Centre Basel, Switzerland. We were pleased to welcome over 400 delegates to BOS 2019, up over 15% on 2018 numbers. Participants attended presentations across 3 work-streams; Discovery Outsourcing, CMC Small Molecule and CMC Biologics Outsourcing content (click to view the BOS 2019 speaker programme).

In addition to the extensive programme, attendees were able to organise 1-to-1 partnering meetings utilising the BOS Events partnering software. This “partnering “ dynamic allows attending buyers to outline outsourcing requirements. Suppliers are able to outline services offered. Buyers and suppliers can then use the partnering platform to arrange 1-to-1 meetings based on areas of mutual interest. Around 1100 partnering meetings took place at BOS 2019, significantly up on the number of meetings organised in 2018.

Click here to read full article /
Click here to view delegate comments following BOS 2019.

PR NEWSWIRE | BIO2BUSINESS NEWS | PARTNER NEWS

Record Numbers Attend BOS 2019 in Basel
BOS 2019 took place on the 19th and 20th of June at the Congress Centre Basel, Switzerland. We were pleased...
Read News in full

Positive Delegate Experience BOS 2019
Comments from participants at BOS BASEL 2019 which took place on the 19th and 20th June at the Congress Centre...
Read News in full

Positive Delegate Experiences at BOS BASEL 2018
Comments from participants at BOS BASEL 2018 which took place on the 19th and 20th June at the Congress Centre...
Read News in full

Featured Presentation - BOS 2018: "Collaborative virtual screening to boost neglected tropical disease discovery". Dr Ben Perry, Senior Discovery Manager, Drugs for Neglected Disease initiative (DNDi)
The NTD Drug Discovery Booster is an innovative collaboration designed to swiftly and efficiently maximise...
Read News in full

Ads from CRO Tracker

LGC
Supporting discovery, development and manufacturing activities

Ads from CRO Tracker

EphyX Neuroscience
Top-quality in vitro electrophysiology for CNS-related preclinical studies

Featured Speaker

photo of Dr Leena Otsoma

Designing Medicines of the Future and Integrating External Discovery Capabilities with Internal Projects

Dr Leena Otsoma, VP Global Medicine Design, Orion Pharma

ABSTRACT: Dr. Leena Otsomaa will speak about changing landscape influencing design of medicines for the future. Many technologies including AI are developing fast and will definately impact to the work of medicinal chemists. Some of the technologies are today in their hype curve and the real value remains to be seen, but critical period is here and now. What are the bottlenecks when traditional drug discovery funnel is changing? Click here to Read More

What's new

Dr Firelli Alonso, Senior Director, External Supply, BioTherapeutics & Vaccines Outsourcing, Pfizer, to present at BOS Basel 2020

Bio2Business welcomes back Firelli Alonso, Pfizer, as a speaker at BOS BASEL 2020

Dr Firelli Alonso, Senior Director, External Supply, BioTherapeutics & Vaccines Outsourcing, Pfizer, will present in the Biologics CMC Outsourcing work-stream at BOS Basel 2020. Her confirmed presentation title is "Agile sourcing strategies for new therapeutic modalities". 

 

Read more

Legacy Pharmaceuticals Switzerland GmbH Confirms Gold Sponsor Package in partnership with SCHOTT Pharmaceutical Systems at BOS Basel 2020

Legacy Pharmaceuticals, a global GMP-compliant contract manufacturer of sterile/aseptic in liquid and powder form and non-sterile semi-solid pharmaceutical products was founded in 1947. The company remains true to its Swiss origins and has built up a justified reputation for excellence, quality and reliability in the industry. FDA approved and globally active, the products Legacy manufacture on behalf of third parties are sold in 112 countries around the world including Japan, Russia, Korea to name a few.

Read more

Laxai Life Sciences Ltd Exhibiting at BOS Basel 2020

Bio2Business is pleased to extend a warm welcome to Laxai Life Sciences who are exhibiting at Booth Number 33. LAXAI’s GMP manufacturing sites (2) located in Hyderabad have a combined reactor capacity of 300KL and further expansions are currently taking place. The sites have in total 14 production blocks used for manufacturing of starting materials and intermediates and 8 clean rooms used for manufacturing of the API. The sites currently supply starting materials, advanced intermediates, and APIs to pharmaceutical, biotech, and animal health companies in US, EU, China, Japan, and ROW.   

Read more